Cervical cancer remains a significant health challenge in the U.S., with nearly one-third of cases resulting in death over the past decade, according to the Centers for Disease Control and Prevention. Hispanic and non-Hispanic Black women are disproportionately affected, with higher rates of diagnosis and mortality compared to white women. The disparity is not due to genetics but to systemic healthcare inequalities.
"Removing barriers so that these women can have access is critical," says Olivia Cardenas-Trowers, M.D., a urogynecologist at Mayo Clinic. She notes that limited transportation, education, and other socioeconomic factors often hinder access to screenings and care, particularly in communities of color.
Building trust between patients and healthcare providers is equally vital. "When they are in the system, being with providers they can trust allows them to communicate problems and access essential screenings like Pap smears," explains Dr. Cardenas-Trowers.
Regular screenings and early detection are key, as cervical cancer in its early stages may not present symptoms. Symptoms like abnormal vaginal bleeding and pain typically appear in later stages when treatment is more difficult.
The biggest risk factor for developing cervical cancer — HPV infection — can be prevented with a vaccine.
To reduce cervical cancer mortality, addressing healthcare access disparities and promoting prevention are essential. Dr. Cardenas-Trowers emphasizes prevention proactive care:
- Establish care with a trusted primary care provider.
- Follow recommended screenings, including Pap smears.
- Get vaccinated against HPV to reduce the primary risk factor for cervical cancer.
Learn more
Learn more about cervical cancer and find a cervical cancer clinical trial at Mayo Clinic.
A version of this article was originally published on the Mayo Clinic News Network.